These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29510462)
1. Development of a pelvic exenteration service at a tertiary referral centre. Dickfos M; Tan SBM; Stevenson ARL; Harris CA; Esler R; Peters M; Taylor DG ANZ J Surg; 2018 Mar; ():. PubMed ID: 29510462 [TBL] [Abstract][Full Text] [Related]
2. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer. van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909 [TBL] [Abstract][Full Text] [Related]
3. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer]. Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427 [No Abstract] [Full Text] [Related]
4. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. PelvEx Collaborative Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308 [TBL] [Abstract][Full Text] [Related]
6. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years. Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856 [TBL] [Abstract][Full Text] [Related]
7. Retrospective review of pelvic malignancies undergoing total pelvic exenteration. Kuhrt MP; Chokshi RJ; Arrese D; Martin EW World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863 [TBL] [Abstract][Full Text] [Related]
8. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes. Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872 [TBL] [Abstract][Full Text] [Related]
9. Short- and long-term outcomes of selective pelvic exenteration surgery in a low-volume specialized tertiary setting. Humphries EL; Kroon HM; Dudi-Venkata NN; Thomas ML; Moore JW; Sammour T ANZ J Surg; 2019 Jun; 89(6):E226-E230. PubMed ID: 31067602 [TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer. Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132 [TBL] [Abstract][Full Text] [Related]
11. Pelvic Exenteration for Locally Advanced Rectal Cancer: an Initial Experience from North-east India. Das G; Sahewalla A; Purkayastha J; Talukdar A; Kalita D; Kamalasanan K; Kakoti L Indian J Surg Oncol; 2022 Sep; 13(3):559-563. PubMed ID: 35280239 [TBL] [Abstract][Full Text] [Related]
12. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion]. Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429 [TBL] [Abstract][Full Text] [Related]
14. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer. Chang KH; Brown KGM; Chen Lau Y; Solomon MJ Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717 [TBL] [Abstract][Full Text] [Related]
15. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma. Quyn AJ; Murthy S; Gould L; Said H; Tiernan J; Sagar P; Antoniou A; Jenkins I; Burns EM Colorectal Dis; 2023 Nov; 25(11):2131-2138. PubMed ID: 37753947 [TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases. Chew MH; Yeh YT; Toh EL; Sumarli SA; Chew GK; Lee LS; Tan MH; Hennedige TP; Ng SY; Lee SK; Chong TT; Abdullah HR; Goh TLH; Rasheed MZ; Tan KC; Tang CL World J Gastrointest Oncol; 2017 May; 9(5):218-227. PubMed ID: 28567186 [TBL] [Abstract][Full Text] [Related]
17. Curative pelvic exenteration: initial experience and clinical outcome. Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871 [TBL] [Abstract][Full Text] [Related]
18. Total pelvic exenteration for primary and recurrent malignancies. Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811 [TBL] [Abstract][Full Text] [Related]
19. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010. Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284 [TBL] [Abstract][Full Text] [Related]
20. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration. Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]